OGN ▼ -0.1% - Organon & Co. $OGN Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting 16-OCT-2026 07:31 AM ET